INSULIN HUMAN vs INSULIN LISPRO-AABC

Compare INSULIN HUMAN (AFREZZA) and INSULIN LISPRO-AABC (LYUMJEV) — clinical data, side effects, and patient experiences.

INSULIN HUMAN

AFREZZA · Insulin

How it works

12.1 Mechanism of Action Insulin lowers blood glucose levels in adult patients with diabetes mellitus by stimulating peripheral glucose uptake by skeletal muscle and fat, and by in...

Approved for

See full prescribing information

Respiratory (inhalation)Tablet

INSULIN LISPRO-AABC

LYUMJEV · Insulin

How it works

12.1 Mechanism of Action The primary activity of LYUMJEV is the regulation of glucose metabolism. Insulins, including insulin lispro-aabc, exert their specific action through bindi...

Approved for

See full prescribing information

Intravenous, SubcutaneousTablet

Quick Comparison

INSULIN HUMANINSULIN LISPRO-AABC

Drug Class

Insulin

Route

Respiratory (inhalation)

Intravenous, Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

INSULIN HUMAN

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

General Unwellness

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

INSULIN LISPRO-AABC

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

General Unwellness

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

FDA Warnings

INSULIN HUMAN

5 WARNINGS AND PRECAUTIONS Hypoglycemia or Hyperglycemia with Changes in Insulin Regimen : Make necessary changes to a patient's insulin regimen under close medical supervision with increased frequency of blood glucose monitoring
2 ) Hypoglycemia (may be life-threatening): Increase frequency of glucose monitoring in patients at higher risk for hypoglycemia and those who have reduced symptomatic awareness of hypoglycemia
4 ) Lung Cancer : In patients with active lung cancer, a prior history of lung cancer, or in patients at risk for lung cancer, consider whether the benefits of AFREZZA use outweigh this potential risk
5 ) Diabetic Ketoacidosis : In patients at risk for DKA, increase the frequency of glucose monitoring and consider changing to alternate route of insulin delivery

INSULIN LISPRO-AABC

5 WARNINGS AND PRECAUTIONS Never share a LYUMJEV prefilled pen or cartridge between patients, even if the needle is changed
Monitor potassium levels in patients at risk for hypokalemia and treat if indicated
Sharing poses a risk for transmission of blood-borne pathogens
, insulin, insulin strength, manufacturer, type, injection site or method of administration) may affect glycemic control and predispose to hypoglycemia [see Warnings and Precautions ( 5

Community Sentiment Analysis

Based on 9 Reddit discussions

INSULIN HUMAN

11%

positive

9 threads

INSULIN LISPRO-AABC

positive

0 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Community Discussions

9 Reddit threads analysed for INSULIN HUMAN

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

38 upvotes

Most discussed side effects in community

Itching (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Medicine Roulette: The Patient Who Played Gacha with Their Meds

Hi! Pharmacist here I am pharmacist in Thailand Have story to tell Some patients forget their doses. Some skip their meds. And then there’s THIS GUY—who decided to turn his diabetes treatment into a f*cking lucky draw. Let me introduce you to the human version of a pharmacy horror story. I was worki

r/pharmacy167421y ago

I switched to nursing

I was a P3 up until last December of last year. I took a leave for mental health and worked at an urgent care. I was in the hospital several times in the psych unit and was really inspired by the nurses who treated me like a human being and switching to nursing has saved my life through all the suic

r/pharmacy88144y ago

Itching

Afrezza, a new inhaled long acting insulin.

r/pharmacy341811y ago

Insulin potency

Veterinary pharmacy tech here. I've worked in a compounding pharmacy for a few years but am currently at an emergency/specialty hospital for dogs and cats only. I am interested in having some input from those of you not involved in vet med, mostly because it seems human medicine has a lot more cont

r/pharmacy1891y ago

How is Exubera pronounced?

I'm presenting proposed guidelines for Afrezza at our DUR Board tomorrow. At some point, I'm sure I'll need to mention Exubera, the flop inhaled insulin from 2006-2007. Does anyone remember how it's pronounced? I'm thinking either "ex-OO-burr-a" or "ex-oo-BEAR-a"?

r/pharmacy11811y ago

HELP!!! Inhaled insulin.

I'm doing a presentation over Afrezza - an inhaled insulin. I know this is not a popular drug but I just wanted to gather information about the popularity of Afrezza. Has anyone ever seen this drug being dispensed at their pharmacy? A few pharmacists that I spoke to said they never dispensed this dr

r/pharmacy10513y ago

FDA recently approved a new inhaled insulin drug called Afrezza

Do you guys see this taking off and replacing injectable insulin as the dominant form for insulin delivery?

r/pharmacy7811y ago

Afrezza

Can someone explain why insulin adsorbed to fumaryl diketopiperazine is significant? Exubera was normal insulin that was just breathed in correct?

r/pharmacy51311y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for INSULIN LISPRO-AABC yet.

INSULIN HUMAN vs INSULIN LISPRO-AABC: What You Should Know

Key Differences

Both INSULIN HUMAN and INSULIN LISPRO-AABC belong to the Insulin class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. INSULIN HUMAN is administered via Respiratory (inhalation), whereas INSULIN LISPRO-AABC uses Intravenous or Subcutaneous. Route of administration can affect onset of action and patient adherence.

Shared Indications

Both medications are approved for See full prescribing information. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Safety Considerations

INSULIN HUMAN carries 4 FDA warnings. INSULIN LISPRO-AABC carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

INSULIN HUMAN vs INSULIN LISPRO→INSULIN LISPRO vs INSULIN LISPRO-AABC→INSULIN GLARGINE vs INSULIN HUMAN→INSULIN GLARGINE vs INSULIN LISPRO-AABC→INSULIN ASPART vs INSULIN HUMAN→INSULIN ASPART vs INSULIN LISPRO-AABC→

Loading comparison data...

INSULIN HUMAN vs INSULIN LISPRO-AABC

Compare INSULIN HUMAN (AFREZZA) and INSULIN LISPRO-AABC (LYUMJEV) — clinical data, side effects, and patient experiences.

INSULIN HUMAN

AFREZZA · Insulin

How it works

12.1 Mechanism of Action Insulin lowers blood glucose levels in adult patients with diabetes mellitus by stimulating peripheral glucose uptake by skeletal muscle and fat, and by in...

Approved for

See full prescribing information

Respiratory (inhalation)Tablet

INSULIN LISPRO-AABC

LYUMJEV · Insulin

How it works

12.1 Mechanism of Action The primary activity of LYUMJEV is the regulation of glucose metabolism. Insulins, including insulin lispro-aabc, exert their specific action through bindi...

Approved for

See full prescribing information

Intravenous, SubcutaneousTablet

Quick Comparison

INSULIN HUMANINSULIN LISPRO-AABC

Drug Class

Insulin

Route

Respiratory (inhalation)

Intravenous, Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

INSULIN HUMAN

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

General Unwellness

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

INSULIN LISPRO-AABC

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

General Unwellness

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

FDA Warnings

INSULIN HUMAN

5 WARNINGS AND PRECAUTIONS Hypoglycemia or Hyperglycemia with Changes in Insulin Regimen : Make necessary changes to a patient's insulin regimen under close medical supervision with increased frequency of blood glucose monitoring
2 ) Hypoglycemia (may be life-threatening): Increase frequency of glucose monitoring in patients at higher risk for hypoglycemia and those who have reduced symptomatic awareness of hypoglycemia
4 ) Lung Cancer : In patients with active lung cancer, a prior history of lung cancer, or in patients at risk for lung cancer, consider whether the benefits of AFREZZA use outweigh this potential risk
5 ) Diabetic Ketoacidosis : In patients at risk for DKA, increase the frequency of glucose monitoring and consider changing to alternate route of insulin delivery

INSULIN LISPRO-AABC

5 WARNINGS AND PRECAUTIONS Never share a LYUMJEV prefilled pen or cartridge between patients, even if the needle is changed
Monitor potassium levels in patients at risk for hypokalemia and treat if indicated
Sharing poses a risk for transmission of blood-borne pathogens
, insulin, insulin strength, manufacturer, type, injection site or method of administration) may affect glycemic control and predispose to hypoglycemia [see Warnings and Precautions ( 5